drhls-logodrhls-logodrhls-logodrhls-logo
  • Home
  • About Us
    • Overview
    • Business
    • People
    • Vision, Mission & Values
    • EHS
    • Facilities
  • Products and R & D
  • Services
  • Investor
    • Statutory Info
    • Corporate Governance
    • Financials
    • Shareholding Pattern
    • Stock Quotes
    • Investor Contact
    • Annual Return
    • Investor Information
  • Media
    • Press Releases
    • Photo Gallery
    • Video Gallery
  • Careers
  • Contact

Statutory Info

  • Home
  • Investor
  • Statutory Info
  • Statutory Info
  • Corporate Governance
  • Financials
  • Shareholding Pattern
  • Stock Quotes
  • Investor Information
  • Annual Return
  • Investor Contact
  • Updates
  • Intimation of Board Meeting
  • Outcome of Board Meeting
  • Preferential Issue

Updates

1st EGM Notice FY.2025-26

EGM Notice

23rd AGM- Proceedings, Voting Results and Scrutinizer Report

Proceedings, VR, ScrutinizerReport DRHABEEB

Intimation + Notice 22nd AGM DRHABEEB

Intimation to SE 04.05.2018

PB – Outcome,LODR, Scrutinizer 22DEC17

Postal Ballot Notice

Outcome+Voting Results – 30.09.2016

Postal Ballot – Outcome + Voting Results – 29.09.2016

2/2016-17 Postal Ballot Notice

2PB Outcome LODR Scrutinizer Report 08.02.2017

Intimation of Board Meeting

FY .2025-26

Intimation of Board Meeting Dt.26.4.2025

FY .2024-25

Intimation of Board Meeting Quarter Ended 31.03.2025

Intimation of Board Meeting Dt.8.3.2025

Intimation of Board Meeting Quarter Ended 31.12.2024

Intimation of Board Meeting Quarter Ended 30.9.2024

Intimation of Board Meeting Quarter Ended 30.6.2024

Intimation of Board Meeting Quarter Ended 31.3.2024

FY .2023-24

Intimation of Board Meeting Quarter Ended 31.12.2023

Intimation of Board Meeting Quarter Ended 30.9.2023

Intimation of Board Meeting Quarter Ended 30.6.2023

Intimation of Board Meeting Quarter Ended 31.3.2023

FY .2022-23

4 Intimation of Book Closure for 26th AGM

Intimation of Board Meeting for Quarter Endign 30.09.2022

Intimation of Board Meetign for Quarter Ending 30.06.2022

Intimation of Board Meeting for Quarter Ending 31.03.2022

Trading_Window

FY .2021-22

3 Intimation of Book Closure for 25th AGM

Cancellation of board meeting for Conversion of Unsecured Loan of Directors

Intimation of Board Meeting for Quarter Endign 31.12.2021

Intimation of Board Meeting for Quarter Ending 30.09.2021

Intimation of board meeting-Conversion of Unsecured Loan of Directors

Intimation Board Meeting for Quarter Ending 30.06.2021

Intimation of Board Meeting for Audited Financial Results-31.03.2021

FY .2020-21

2 Intimation of Book closure of 24th AGM

Intimation of Board Meeting Quarter Endign 31.12.2020

Intimation of Board Meeting Quarter Ending 30.09.2020

Intimation of board meeting Quarter Ending-30.06.2020

Cancellation of board meeting Quarter Ending 31.03.2020

Intimation of Board Meeting for Quarter Ending 31.03.2020

Intimation of Board Meeting-31.03.2020

FY .2019-20

1 Intimation of Book Closure-23rd AGM

Intimation of Board Meeting for approval of Directors Report-2019

Intimation of Board Meeting for conversion of warrants

Intimation of Board Meeting for Quarter Ended 31.12.2019

Intimation of Board Meeting Quarter ending 31.12.2019

Intimation of Board Meeting Quarter Ending-30.09.2019

Intimation of Board Meeting Quarter Ending-30.06.2019

Meeting Updates-30.06.2019

Intimation Mar1.20 Qtr

Intimation Mar 20 Qtr

Intimation Dec 19 Qtr

Intimation Sept 19 Qtr

Intimation June 19 Qtr

Intimation Sept 18 Qtr

Intimation Jun 18 Qtr

Intimation Mar 18 Qtr

Intimation Dec 17 Qtr

Intimation Sept 17 Qtr

Intimation Jun 17 Qtr

Intimation Mar 17 Qtr

Intimation Dec 16 Qtr

Intimation Sept 16 Qtr

Intimation Jun 16 Qtr

Intimation Mar 16 Qtr

Outcome of Board Meeting

FY .2025-26

Outcome of Board Meeting Dt.30.04.2025

FY .2024-25

Outcome of Board Meeting Quarter ended 31.03.2025

Outcome of Board Meeting Dt.8.3.2025

Outcome of Board Meeting Quarter ended 31.12.2024

Outcome of Board Meeting Quarter ended 30.9.2024

Outcome of Board Meeting Quarter ended 30.6.2024

Outcome of Board Meeting Quarter ended 31.3.2024

FY .2023-24

Outcome of Board Meeting Quarter ended 31.12.2023

Outcome of Board Meeting Quarter ended 30.9.2023

Outcome of Board Meeting Quarter ended 30.6.2023

Outcome of Board Meeting Quarter ended 31.3.2023

FY .2022-23

Outcome of Board Meeting for Quarter Ending-30.09.2022

Outcome of Board Meeting for Quarter Ending 30.06.2022

Outcome of Board Meeting for Quarter Ending 31.03.2022

FY .2021-22

Outcome of Board Meeting for Quarter Ending 31.12.2021

Outcome of Board Meeting for Quarter Ending 30.09.2021

Outcome of Board Meeting for Quarter Ending-30.06.2021

Outcome of Board Meeting for Quarter 31.03.2021

FY .2020-21

Outcome of Board Meeting to appoint casual Vacancy

Outcome of Board Meeting Ending 31.12.2020

Outcome of Board Meeting Quarter Ending 30.09.2020

Outcome of Board Meeting Quarter Ending 30.06.2020

Outcome of board meeting Quarter Ending-31.03.2020

Outcome of board meeting With Cash Flow Quarter Ending-31.03.2020

FY .2019-20

Outcome of Board Meeting for conversion of warrants

Outcome of Board Meeting for Misc Items

Outcome of Board Meeting for Quarter Ended 31.12.2019

Outcome of Board Meeting for Quarter-31.12.2019

Outcome of Board Meeting Quarter ended-30.09.2019

Outcome of Board Meeting CS & Quarter Ended 30.06.2019

Outcome Mar 20 Qtr

Outcome Dec 19 Qtr

Outcome Sep 19 Qtr

Outcome June 19 Qtr

Outcome Mar 19 Qtr

Outcome Dec 18 Qtr

Outcome Sept 18 Qtr

Outcome June 18 Qtr

Outcome Mar 18 Qtr

Outcome Dec 17 Qtr

Outcome Sept 17 Qtr

Outcome Jun 17 Qtr

Outcome Mar 17 Qtr

Outcome Dec 16 Qtr

Outcome Sept 16 Qtr

Outcome Jun 16 Qtr

Outcome Mar 16 Qtr

Preferential Issue

FY.2025.26

Valuation Report
Annexure V
Annexure IV

Our Company

  • Company Overview
  • Business
  • People
  • Vision, Mission & Values
  • EHS
  • Our Facilities

Products and R&D

  • Stem Cell R&D
  • New Drug Discovery
  • RNA Interference
  • Molecular Biomarkers
  • Medical Devices

Services

  • Molecular Diagnostics
  • Stem Cell Therapy
  • Clinical Services
  • Contract Research Organization
  • Academic Services

Investors

  • Stock Quotes
  • Shareholding Pattern
  • Investor Contact
  • Financials
  • Corporate Governance
  • Statutory Info

Registered Office

  • 6-3-354/13/B2, Suryateja Apartments, Hindinagar, Punjagutta, Hyderabad-500082, Telangana, India
  • info@drhlsl.com
© 2024 HLS. All Rights Reserved.